Novoprotein Scientific Inc. (SHA:688137)
China flag China · Delayed Price · Currency is CNY
42.19
+1.57 (3.87%)
At close: Mar 6, 2026

Novoprotein Scientific Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-54.4212.8490.72149.01
Depreciation & Amortization
31.3222.5520.469.2
Other Amortization
6.111.581.380.78
Loss (Gain) From Sale of Assets
-0.14-0-0.04-0.03
Asset Writedown & Restructuring Costs
6.70.090.080.15
Loss (Gain) From Sale of Investments
-2.76-17.19-4.16-0.85
Provision & Write-off of Bad Debts
2.09-1.581.223.9
Other Operating Activities
4.4836.919.6315.17
Change in Accounts Receivable
14.6462.8-57.73-52.73
Change in Inventory
-14.81-41.26-51.84-30.96
Change in Accounts Payable
10.76-8.62-15.18-29.11
Change in Other Net Operating Assets
12.6310.487.017
Operating Cash Flow
13.3269.163.3870.97
Operating Cash Flow Growth
-80.75%1948.16%-95.24%-27.26%
Capital Expenditures
-44.88-44.94-36.77-69.95
Sale of Property, Plant & Equipment
00.010.010
Investment in Securities
-129.34-56.6-963.325
Other Investing Activities
16.1520.110.61
Investing Cash Flow
-158.06-81.42-999.45-43.95
Long-Term Debt Repaid
-26.5-17.32-11.34-4.85
Total Debt Repaid
-26.5-17.32-11.34-4.85
Net Debt Issued (Repaid)
-26.5-17.32-11.34-4.85
Issuance of Common Stock
--1,742117.67
Repurchase of Common Stock
-10.35---
Common Dividends Paid
-35.09-35.09--16.29
Other Financing Activities
-0.63-1.522.51-2
Financing Cash Flow
-72.56-53.931,73394.53
Foreign Exchange Rate Adjustments
0.620.542.64-0.79
Net Cash Flow
-216.69-65.65739.94120.75
Free Cash Flow
-31.5724.22-33.391.02
Free Cash Flow Growth
----98.82%
Free Cash Flow Margin
-24.75%15.81%-12.62%0.30%
Free Cash Flow Per Share
-0.450.34-0.580.03
Cash Income Tax Paid
15.272.6358.6371.24
Levered Free Cash Flow
-21.190.36-68.42-40.11
Unlevered Free Cash Flow
-18.952.6-65.89-38.99
Change in Working Capital
19.9413.97-125.93-106.35
Source: S&P Global Market Intelligence. Standard template. Financial Sources.